Latest Breaking News On - Institutional trading of recursion pharmaceuticals - Page 1 : comparemela.com

Christopher Gibson Sells 50,000 Shares of Recursion Pharmaceuticals, Inc (NASDAQ:RXRX) Stock

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Christopher Gibson sold 50,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 5th. The shares were sold at an average price of $8.42, for a total transaction of $421,000.00. Following the completion of the sale, the chief executive officer now owns […]

Christopher gibsonRecursion pharmaceuticalsNeedham companyProfund advisorsRecursion pharmaceuticals incInstitutional trading of recursion pharmaceuticalsNorges bankSecurities exchange commissionGladstone institutional advisoryNews ratings for recursion pharmaceuticals dailyCitigroup incQuarter for recursion pharmaceuticalsRecursion pharmaceuticals company profileRecursion pharmaceuticals trading downPathstone family officeGet free report

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down Following Insider Selling

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Gap Down Following Insider Selling
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tina marriott larsonNews ratings for recursion pharmaceuticals dailyNational bankVident investment advisoryRecursion pharmaceuticals incBaldwin brothersInstitutional trading of recursion pharmaceuticalsAmeritas investment partners incRecursion pharmaceuticals stock downSecurities exchange commissionRecursion pharmaceuticalsNeedham companyManufacturers life insurance companyGet free reportMarriott larsonExchange commission

Tina Marriott Sells 8,000 Shares of Recursion Pharmaceuticals, Inc (NASDAQ:RXRX) Stock

Tina Marriott Sells 8,000 Shares of Recursion Pharmaceuticals, Inc (NASDAQ:RXRX) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Tina marriottFirst horizon advisors incRecursion pharmaceuticals trading downSecurities exchange commissionRecursion pharmaceuticals incQuarter for recursion pharmaceuticalsNews ratings for recursion pharmaceuticals dailyComerica bankRecursion pharmaceuticals company profileNeedham companyRecursion pharmaceuticalsChina universal asset management coNational bankInstitutional trading of recursion pharmaceuticalsGet free reportExchange commission

Insider Selling: Recursion Pharmaceuticals, Inc (NASDAQ:RXRX) CEO Sells $430,743 34 in Stock

Insider Selling: Recursion Pharmaceuticals, Inc (NASDAQ:RXRX) CEO Sells $430,743 34 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Christopher gibsonQuarter for recursion pharmaceuticalsNews ratings for recursion pharmaceuticals dailyRecursion pharmaceuticals incRecursion pharmaceuticalsPrincipal financial group incBaldwin brothersAmeritas investment partners incRecursion pharmaceuticals company profileRecursion pharmaceuticals stock performanceManufacturers life insurance companyNational bankJpmorgan chase coNeedham companySecurities exchange commissionInstitutional trading of recursion pharmaceuticals

Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 6 1% After Insider Selling

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) dropped 6.1% during trading on Monday after an insider sold shares in the company. The company traded as low as $10.50 and last traded at $10.51. Approximately 3,359,534 shares traded hands during trading, a decline of 54% from the average daily volume of 7,262,308 shares. […]

Christopher gibsonMichael secoraRecursion pharmaceuticals company profileSecurities exchange commissionRecursion pharmaceuticalsRecursion pharmaceuticals stock performanceJpmorgan chase coNeedham companySumitomo mitsui trust holdings incNews ratings for recursion pharmaceuticals dailyNvidia corpInstitutional trading of recursion pharmaceuticalsInvestment managementMubadala investment coRecursion pharmaceuticals incGet free report